The Food and Drug Administration Friday took steps to encourage and streamline the development of COVID-19 tests whose specimens are collected at home by patients. To support this effort, the agency issued revised guidance for these tests’ development and also offers a voluntary template that developers can use to secure emergency use authorizations.

Related News Articles

Headline
The Food and Drug Administration and Centers for Disease Control and Prevention July 7 at 12 p.m. ET will host a webinar on decontaminating respirators for…
Headline
The blanket data reporting exceptions and extensions implemented in March across Medicare quality reporting and value-based payment programs for hospitals…
Headline
The House of Representatives last night passed by unanimous consent legislation (S. 4116) extending the Paycheck Protection Program loan application period…
Perspective
As James Madison wrote in the First Amendment of our Bill of Rights, we have the right to “petition the government for a redress of grievances.” We also have…
Headline
The Federal Communications Commission’s Rural Health Care Program will carry forward up to $197.98 million in unused funds from prior years to increase…
Headline
Oklahoma voters yesterday approved expanding the state’s Medicaid initiative, the first state to do so during the COVID-19 pandemic. The ballot question, which…